NCT06247904

NIBS Therapy in Subacute Spinal Cord Injury

Enrolling by Invitation
NAAges 18–80InterventionalTreatment
Albert Einstein Healthcare Network
~20 participants
Updated 2025-04-30 on ClinicalTrials.gov
What's tested:Active rTMSsham rTMS

At a glance

Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Eligibility - (Percentage candidates eligible of screened patients)
Measured over 21 months (Recruitment period)
+5 more outcomes measured
Traumatic Spinal Cord Injury
Tetraplegia/Tetraparesis

NCT06247904

Where you'd take part

This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.

  • Jefferson Moss-Magee Rehabilitation - Elkins Park

    Elkins Park, Pennsylvaniano site contact published

Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.

  • Dylan J Edwards, PhD · PRINCIPAL_INVESTIGATOR · Albert Einstein Healthcare Network

This trial hasn't published a contact. View it on ClinicalTrials.gov

  • Eligibility - (Percentage candidates eligible of screened patients)21 months (Recruitment period)

    The proportion of patients who can take part in the study, whether they later agree to or not.

  • Recruitment - (Percentage candidates enrolled of approached patients)21 months (Recruitment period)

    The proportion of eligible patients who agree to take part in the study.

  • Adherence to intervention - (Percentage candidates who dropout during the intervention period of enrolled candidates)2 years (Duration of human subjects' involvement)

    Proportion of intervention-related dropouts.

  • Adherence to outcome assessment - (Percentage candidates who do not complete outcome assessments of enrolled candidates)2 years (Duration of human subjects' involvement)

    Proportion of patients that complete the assessments at the start and the end of the intervention.

  • Retention - (Percentage candidates who do not complete 6-month follow up of enrolled candidates)2 years (Duration of human subjects' involvement)

    The number of patients who drop out or were 'lost' at the 6-month follow-up.

  • Adverse Events2 years (Duration of human subjects' involvement)

    Rate of adverse and serious adverse events